Protease-triggered unveiling of bioactive nanoparticles.
about
Smart nanosystems: Bio-inspired technologies that interact with the host environmentCPP-Assisted Intracellular Drug Delivery, What Is Next?Aptamer-crosslinked microbubbles: smart contrast agents for thrombin-activated ultrasound imaging.Novel molecular and nanosensors for in vivo sensingActivatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases.Targeting of drugs and nanoparticles to tumors.Insights into atherosclerosis using nanotechnologyEmerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumorsGrowth factor delivery-based tissue engineering: general approaches and a review of recent developmentsGlypican-3 targeting of liver cancer cells using multifunctional nanoparticlesLayer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxiaFRET-based and other fluorescent proteinase probes.siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells.Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.Biotargeted nanomedicines for cancer: six tenets before you beginCurb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.Recent advances in nanobiotechnology and high-throughput molecular techniques for systems biomedicine.Cell-penetrating peptides: achievements and challenges in application for cancer treatment.Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.Strategies for in vivo imaging of enzyme activity: an overview and recent advances.Cell-penetrating peptides: A tool for effective delivery in gene-targeted therapies.Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine.Applying nanomedicine in maladaptive inflammation and angiogenesis.Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake.Nanoparticle-based probes to enable noninvasive imaging of proteolytic activity for cancer diagnosis.Strategies for improving drug delivery: nanocarriers and microenvironmental priming.In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery.Oligonucleotide delivery by cell-penetrating "striped" nanoparticles.Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology.Enzymatic activity inside a DNA/peptide complex.Effect of partial PEGylation on particle uptake by macrophages.Sustained-release synthetic biomarkers for monitoring thrombosis and inflammation using point-of-care compatible readouts.Oligonucleotide Delivery by Cell-Penetrating “Striped” NanoparticlesRetinoic Acid Decorated Albumin-Chitosan Nanoparticles for Targeted Delivery of Doxorubicin Hydrochloride in Hepatocellular Carcinoma
P2860
Q26776370-9BF6CE2B-00E8-4D02-9780-59B4493E8C97Q28079386-1D92DA7D-DF22-485C-8CE9-8FD6DBD7DE96Q30446764-98211DDD-CC58-4BF3-9DAD-6CA51E6F1CEBQ30450856-10C92D6F-1E56-4DA2-855F-AB1FFACB74EBQ33733160-C86DEA1F-E3CA-4EC1-8FE4-07346056A7C7Q33751710-D91CCFE4-5B23-4781-9B38-0D9C1CBF842DQ33824820-7C7C7B10-635C-4914-8D64-4107B0276D95Q33839384-5DE9A167-2D2B-42C4-8552-1961951D19B8Q33855309-02B166F9-35BD-4864-9472-72B1E4907639Q34548765-1D31E87F-8526-4547-BE43-B761B3463C5AQ34675546-38965501-4AE3-4033-BAC2-13929FB6483DQ35074580-C09CBEE5-62F5-4316-A13B-B936F3D4AC78Q35086168-ED953DC3-C1EB-4D2F-AD96-E8D2ABD2D93CQ35207239-33C306B8-DA7A-469F-8AE4-33E18225F1B2Q35783096-24576E56-DCA0-44C2-AE14-4ACA95396463Q36612939-DB3853B5-1332-48E9-A7E3-A97B9AB15046Q36814280-E61B3EAB-81ED-4F9E-80ED-80CB7CDD73D2Q36854231-14E3FCEA-CF2D-470B-8028-A02BC88F8354Q37462618-829241FD-AFFA-43DC-9A97-FEB4F9D613FCQ37594526-0086EBA3-7CAB-41E5-850B-DDD5216D4B37Q37775972-5B9920E1-8724-4572-861E-30BFC017CDE3Q37873318-89CF9560-F276-4AE2-9E35-E0BAB8C4DC7AQ38198590-07B115E6-CC3A-49A6-B12D-52D42CEF4023Q38235410-6CB75126-7B2E-418F-B44E-379F173C15E5Q38557650-63DB228E-A16B-4CC8-AA9C-B5A478C88CDCQ38658534-E2D0889F-FAC7-4F68-B131-1D5B171AA97CQ38740666-073CB63C-C166-4C3A-9F56-0AA515EC64D0Q38837131-086F8083-F8F8-4D0B-88E3-536ADE92DA06Q38968910-35DB10C6-3C79-4D96-A629-6999851B12C5Q39761175-CDD3F23E-2DBD-45B4-9806-DB772BA0C33CQ42077942-4D63C124-E30E-4FE9-9DEE-EA8A53357A24Q42080674-DA3D85D6-75C7-421B-AFB5-25EC0E1B5503Q42145728-DCAD84F9-8A34-423C-9FB4-6E9837916D46Q47794660-8C7A6B7C-554D-4879-AA21-CDF1345B09E5Q48916206-1368CA9C-927C-49FD-A4DD-757A0E13461BQ54606553-8BF1A88E-44DD-4FBC-860F-572B713B2D60Q57910117-EA2C081A-40E4-41C9-976D-3196440AD653Q59016832-4A316692-670D-480E-830B-21F7EB5520CF
P2860
Protease-triggered unveiling of bioactive nanoparticles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protease-triggered unveiling of bioactive nanoparticles.
@en
Protease-triggered unveiling of bioactive nanoparticles.
@nl
type
label
Protease-triggered unveiling of bioactive nanoparticles.
@en
Protease-triggered unveiling of bioactive nanoparticles.
@nl
prefLabel
Protease-triggered unveiling of bioactive nanoparticles.
@en
Protease-triggered unveiling of bioactive nanoparticles.
@nl
P2093
P2860
P356
P1433
P1476
Protease-triggered unveiling of bioactive nanoparticles.
@en
P2093
Amit Agrawal
Dal-Hee Min
Geoffrey von Maltzahn
Ji-Ho Park
Matthew E Lord
Michael J Sailor
Sangeeta N Bhatia
Todd J Harris
P2860
P304
P356
10.1002/SMLL.200701319
P577
2008-09-01T00:00:00Z